Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01883063
Other study ID # WRx-001
Secondary ID
Status Terminated
Phase N/A
First received June 14, 2013
Last updated April 12, 2015
Start date July 2013
Est. completion date December 2014

Study information

Verified date April 2015
Source Sonoma Orthopedic Products, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective multi-site study. Subjects with distal radius fractures will be enrolled. Subjects will be treated surgically with a Sonoma WRx™ device or managed non-operatively with a splint or cast. Subjects will be enrolled in each group according to physician's standard of care (either casting/splinting or surgery) for distal radius fractures. Subjects will be enrolled based on the study's inclusion/exclusion criteria with a final qualifying decision made by a group of three independent adjudicators. The final qualifying review should allow for similar patient groups within each arm of the study due to the variability that can arise in fracture classification. Review by the adjudicators should be completed within 1 week.


Recruitment information / eligibility

Status Terminated
Enrollment 9
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Closed extra-articular distal radius fracture or a minimally displaced intra-articular fracture

- Fracture classified as an AO/OTA A2, A3, C1 or C2 with or without an ulnar styloid fracture

- Must be treated within the first 14 days of injury,

- Male or female greater than or equal to 65 years of age.

- Able to understand the requirements of the study, provide a written informed consent and comply with the study protocol

- Ability to understand and provide written authorization for use and disclosure of personal health information

- Fracture that can be treated closed with or without closed reduction

Exclusion Criteria:

- Concomitant contralateral or ipsilateral upper extremity fractures

- Ipsilateral ulna (excluding styloid) fracture

- Open fracture

- Previous ipsilateral distal radius fracture in the 2 years prior to enrollment with deformity

- Unstable distal radioulnar joint after fracture fixation

- Fractures where the transverse fracture line is less than 10mm from the distal radius joint surface

- Artery or Nerve injury secondary to fracture

- History of alcoholism

- Currently on chemotherapy or radiation therapy

- Currently on worker's compensation

- Rheumatoid arthritis or other inflammatory arthropathies.

- History of chronic pain issues or psychiatric disorder that precludes reliable follow-up.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Surgical Treatment
Patients will be treated for distal radius fractures surgically with a WRx™ Intramedullary Nail
Non surgical Treatment (Cast or splint)
Patients will be treated for distal radius fractures non surgically with a cast or splint

Locations

Country Name City State
United States University of Missouri Columbia Missouri
United States John Peter Smith Hospital Fort Worth Texas
United States Cadence Health Winfield Illinois

Sponsors (1)

Lead Sponsor Collaborator
Sonoma Orthopedic Products, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Composite Patient Outcomes Over Time Patient outcomes will be measured with the DASH, PRWE and a patient questionnaire. Data will be collected at 2, 6, 12, 26, 52 weeks
Secondary Change in Composite Functional Outcomes Over Time Measurements of range of motion, strength and fracture healing will be used to determine functional outcomes. Data will be collected at 2, 6, 12, 26, 52 weeks